{
  "report_rows": [
    {
      "kpi": "Adjusted revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$5.00B vs. cons $4.99B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$1.98 vs. cons $1.95",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted operating margin",
      "prediction": "IN-LINE",
      "answer": "pred ~33.2% vs. cons 33.0%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Organic revenue growth",
      "prediction": "UNCHANGED",
      "answer": "guide ~2.0% midpoint (1%-3%) vs. cons 1.7% (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted EPS",
      "prediction": "UNCHANGED",
      "answer": "guide ~$8.15 midpoint ($8.00-$8.30) vs. cons $8.14 (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted operating margin",
      "prediction": "UNCHANGED",
      "answer": "guide ~34.0% vs. cons 33.9% (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted revenue growth",
      "prediction": "UNCHANGED",
      "answer": "guide ~7.0% midpoint (6%-8%) vs. cons 6.7% (2H2026)",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": 6.5,
  "day1_confidence": "LOW",
  "day5_residual_pct": 3.2,
  "day5_path": "FADE",
  "day5_rationale": "A controlled trough quarter, modest EPS upside and reaffirmed guidance should drive an initial relief rally, but the gain should partially fade because the 2H2026 acceleration remains back-end-loaded and execution-dependent; limited estimate increases beyond 2026 constrain follow-through.",
  "day5_confidence": "LOW"
}